Overview
Zimmer Biomet Holdings, Inc., based in the United States, specializes in the design, manufacture, and marketing of orthopedic reconstructive products, sports medicine, biologics, extremities and trauma products, office-based technologies, spine, craniomaxillofacial, and thoracic products, dental implants, and related surgical products. As a leader in the medical devices sector, the company focuses heavily on musculoskeletal healthcare. Zimmer Biomet is renowned for its innovative solutions that enhance patient outcomes in hospitals and clinics worldwide. Key projects involve the development of technologies that improve the precision and recovery times of orthopedic surgeries, alongside significant investments in robotics and data analytics to optimize surgical efficiency and patient care. These initiatives underscore Zimmer Biomet's commitment to advancing healthcare through cutting-edge medical technology.
AI+ Ask Fintel’s AI assistant about Zimmer Biomet Holdings, Inc..
Thinking about good questions…
Basic Stats
The share price of Zimmer Biomet Holdings, Inc. as of September 5, 2025 is €91.00 / share. This is an increase of 1.00% from the prior week. The market cap (or net worth) of Zimmer Biomet Holdings, Inc. as of September 5, 2025 is €18,008.90 MM.
The Factor Analysis chart (below right) shows a view of Zimmer Biomet Holdings, Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 18,008.90 MM |
| EV | |
| Shares Out. | 197.90 MM |
| Earnings Date | |
| EPS (TTM) | 4.16 |
| Dividend Yield | |
| Ex-Dividend Date | 2025-09-30 |
| Borrow Rate | |
| Short Shares Avail. | |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | |
| Volatility (1 yr) | 0.19 |
| Beta | 0.99 |
| Sharpe Ratio (1 yr) | |
| Sortino Ratio (1 yr) |
| PE Ratio | |
| Price/Book | |
| Price/TBV | |
| Book/Market | |
| EBIT/EV | |
| EBIT(3yr avg)/EV | |
| ROA | 0.04 |
| ROE | 0.06 |
| ROIC | 0.04 |
| CROIC | 0.01 |
| OCROIC | 0.08 |
| Implied Volatility | |
| Put/Call OI Ratio |
| Growth | 59.16 /100 |
| Profitability | 56.34 /100 |
| Quality Score | 53.59 /100 |
| Value Score | |
| Momentum Score | |
| Stability (Low Vol) Score | 88.68 /100 |
| Analyst Sentiment | |
| Fund Sentiment | 16.80 /100 |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE | 7.00 /9 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Zimmer Biomet Holdings, Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2025-07-08 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2025-05-06 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2025-05-06 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-05-06 | Stifel | Buy | Buy | Maintains |
| 2025-05-06 | Raymond James | Outperform | Outperform | Maintains |
| 2025-05-06 | Goldman Sachs | Neutral | Neutral | Maintains |
| 2025-02-10 | Truist Securities | Hold | Hold | Reiterate |
| 2025-02-10 | Barclays | Underweight | Underweight | Maintains |
| 2025-02-07 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-02-07 | JMP Securities | Market Outperform | Market Outperform | Reiterate |
| 2025-02-07 | Raymond James | Outperform | Outperform | Maintains |
| 2025-02-07 | Needham | Hold | Hold | Reiterate |
| 2025-01-29 | Needham | Hold | Hold | Reiterate |
| 2025-01-23 | Stifel | Buy | Buy | Maintains |
| 2024-12-18 | Truist Securities | Hold | Hold | Maintains |
| 2024-12-17 | JP Morgan | Neutral | Overweight | Upgrade |
| 2024-12-12 | Barclays | Underweight | Underweight | Maintains |
| 2024-11-04 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-11-01 | Truist Securities | Hold | Hold | Maintains |
| 2024-10-31 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2024-10-31 | Needham | Hold | Reiterate | |
| 2024-10-15 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-10-14 | Raymond James | Outperform | Outperform | Maintains |
| 2024-10-08 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-10-03 | BTIG | Buy | Buy | Maintains |
| 2024-10-01 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2024-09-17 | Needham | Hold | Reiterate | |
| 2024-09-16 | JP Morgan | Neutral | Neutral | Maintains |
| 2024-09-13 | Truist Securities | Hold | Hold | Reiterate |
| 2024-09-10 | Canaccord Genuity | Hold | Hold | Maintains |
| 2024-09-10 | Wolfe Research | Peer Perform | Initiate | |
| 2024-09-06 | TD Cowen | Hold | Hold | Maintains |
| 2024-09-05 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2024-09-05 | Truist Securities | Hold | Hold | Maintains |
| 2024-08-20 | Canaccord Genuity | Hold | Hold | Maintains |
| 2024-08-08 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-08-08 | UBS | Sell | Sell | Maintains |
| 2024-08-08 | Raymond James | Outperform | Outperform | Maintains |
| 2024-08-08 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2024-08-08 | Baird | Outperform | Outperform | Maintains |
| 2024-08-08 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-08-08 | Needham | Hold | Reiterate | |
| 2024-07-16 | Truist Securities | Hold | Hold | Maintains |
| 2024-07-15 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2024-07-10 | Citigroup | Neutral | Neutral | Maintains |
| 2024-07-02 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2024-07-01 | Piper Sandler | Overweight | Neutral | Downgrade |
| 2024-05-31 | Barclays | Underweight | Underweight | Maintains |
| 2024-05-30 | Goldman Sachs | Neutral | Initiate | |
| 2024-05-30 | Needham | Hold | Reiterate | |
| 2024-05-21 | Argus Research | Hold | Buy | Upgrade |
| 2024-05-17 | Needham | Hold | Reiterate | |
| 2024-05-03 | Truist Securities | Hold | Hold | Maintains |
| 2024-05-03 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-05-02 | Needham | Hold | Reiterate | |
| 2024-04-04 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2024-04-03 | Citigroup | Neutral | Neutral | Maintains |
| 2024-02-23 | Canaccord Genuity | Hold | Hold | Reiterate |
| 2024-02-12 | Barclays | Underweight | Underweight | Maintains |
| 2024-02-09 | JP Morgan | Neutral | Neutral | Maintains |
| 2024-02-09 | Truist Securities | Hold | Hold | Maintains |
| 2024-02-09 | RBC Capital | Outperform | Outperform | Reiterate |
| 2024-01-12 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-01-04 | Evercore ISI Group | Outperform | In-Line | Downgrade |
| 2024-01-03 | Raymond James | Outperform | Outperform | Maintains |
| 2023-12-22 | Truist Securities | Hold | Hold | Maintains |
| 2023-12-04 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2023-11-13 | JMP Securities | Market Outperform | Market Outperform | Maintains |
| 2023-11-09 | Raymond James | Outperform | Outperform | Maintains |
| 2023-11-08 | JP Morgan | Neutral | Neutral | Maintains |
| 2023-11-08 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2023-10-20 | Roth MKM | Neutral | Initiate | |
| 2023-10-02 | Citigroup | Neutral | Neutral | Maintains |
| 2023-08-28 | BTIG | Neutral | Buy | Upgrade |
| 2023-08-02 | Morgan Stanley | Equal-Weight | Equal-Weight | Reiterate |
| 2023-08-02 | Truist Securities | Hold | Hold | Maintains |
| 2023-08-02 | JMP Securities | Market Outperform | Market Outperform | Reiterate |
| 2023-08-02 | Oppenheimer | Outperform | Outperform | Reiterate |
| 2023-08-02 | Barclays | Underweight | Underweight | Maintains |
| 2023-07-19 | Truist Securities | Hold | Hold | Maintains |
| 2023-06-28 | Baird | Outperform | Outperform | Reiterate |
| 2023-05-31 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2023-05-18 | Stifel | Buy | Buy | Maintains |
| 2023-05-18 | Truist Securities | Hold | Hold | Maintains |
| 2023-05-04 | Barclays | Underweight | Maintains | |
| 2023-05-03 | Truist Securities | Hold | Maintains | |
| 2023-05-03 | Citigroup | Neutral | Maintains | |
| 2023-05-03 | Morgan Stanley | Equal-Weight | Maintains | |
| 2023-05-03 | B of A Securities | Underperform | Neutral | Upgrade |
| 2023-05-03 | RBC Capital | Outperform | Maintains | |
| 2023-05-03 | Baird | Outperform | Maintains | |
| 2023-05-03 | Raymond James | Outperform | Maintains | |
| 2023-05-03 | Bernstein | Market Perform | Maintains | |
| 2023-05-03 | JMP Securities | Outperform | Maintains | |
| 2023-04-11 | Evercore ISI Group | In-Line | Outperform | Upgrade |
| 2023-03-31 | Jefferies | Underperform | Hold | Upgrade |
| 2023-03-29 | UBS | Sell | Initiate | |
| 2023-03-10 | Piper Sandler | Neutral | Overweight | Upgrade |
| 2023-02-07 | JMP Securities | Market Outperform | Reiterate | |
| 2023-02-06 | Morgan Stanley | Equal-Weight | Maintains | |
| 2023-02-06 | Truist Securities | Hold | Maintains | |
| 2023-02-06 | Oppenheimer | Outperform | Maintains | |
| 2023-01-11 | JP Morgan | Neutral | Maintains | |
| 2023-01-09 | RBC Capital | Sector Perform | Outperform | Upgrade |
| 2023-01-06 | Morgan Stanley | Equal-Weight | Maintains | |
| 2023-01-05 | Raymond James | Market Perform | Outperform | Upgrade |
| 2023-01-03 | Evercore ISI Group | Outperform | In-Line | Downgrade |
| 2022-12-20 | Truist Securities | Hold | Maintains | |
| 2022-12-12 | Citigroup | Neutral | Maintains | |
| 2022-11-23 | Wells Fargo | Underweight | Equal-Weight | Upgrade |
| 2022-11-03 | RBC Capital | Sector Perform | Maintains | |
| 2022-11-03 | Citigroup | Neutral | Maintains | |
| 2022-10-18 | Barclays | Underweight | Initiate | |
| 2022-10-12 | Jefferies | Underperform | Initiate | |
| 2022-08-03 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-07-18 | Stifel | Buy | Maintains | |
| 2022-07-15 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-05-27 | Needham | Buy | Hold | Downgrade |
| 2022-05-17 | Citigroup | Neutral | Maintains | |
| 2022-05-04 | RBC Capital | Sector Perform | Maintains | |
| 2022-05-04 | SVB Leerink | Outperform | Maintains | |
| 2022-03-21 | Goldman Sachs | Buy | Maintains | |
| 2022-03-02 | Loop Capital | Buy | Hold | Downgrade |
| 2022-02-09 | Loop Capital | Buy | Maintains | |
| 2022-02-08 | RBC Capital | Sector Perform | Maintains | |
| 2022-02-08 | JMP Securities | Market Outperform | Maintains | |
| 2022-02-08 | Truist Securities | Buy | Maintains | |
| 2022-02-08 | Deutsche Bank | Hold | Maintains | |
| 2022-02-08 | Wells Fargo | Underweight | Maintains | |
| 2022-02-08 | Canaccord Genuity | Buy | Hold | Downgrade |
| 2022-02-08 | SVB Leerink | Outperform | Maintains | |
| 2022-02-08 | Needham | Buy | Maintains | |
| 2022-02-02 | UBS | Buy | Neutral | Downgrade |
| 2022-01-21 | Needham | Buy | Maintains | |
| 2022-01-19 | Wells Fargo | Overweight | Underweight | Downgrade |
| 2022-01-10 | BTIG | Buy | Neutral | Downgrade |
| 2022-01-07 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
| 2022-01-04 | Piper Sandler | Overweight | Neutral | Downgrade |
| 2021-12-21 | Truist Securities | Buy | Maintains | |
| 2021-12-10 | RBC Capital | Sector Perform | Initiate | |
| 2021-12-09 | Needham | Strong Buy | Buy | Downgrade |
| 2021-12-07 | Loop Capital | Buy | Initiate | |
| 2021-11-23 | Argus Research | Buy | Hold | Downgrade |
| 2021-11-05 | JMP Securities | Market Outperform | Maintains | |
| 2021-11-05 | Jefferies | Buy | Maintains | |
| 2021-10-05 | Barclays | Overweight | Maintains | |
| 2021-08-04 | Canaccord Genuity | Buy | Maintains | |
| 2021-08-04 | Oppenheimer | Outperform | Maintains | |
| 2021-08-04 | SVB Leerink | Outperform | Maintains | |
| 2021-05-25 | Barclays | Overweight | Initiate | |
| 2021-05-11 | JMP Securities | Market Outperform | Maintains | |
| 2021-05-05 | Canaccord Genuity | Buy | Maintains | |
| 2021-05-05 | Raymond James | Strong Buy | Maintains | |
| 2021-05-05 | SVB Leerink | Outperform | Maintains | |
| 2021-04-09 | Northland Capital Markets | Market Perform | Outperform | Upgrade |
| 2021-03-01 | Wells Fargo | Overweight | Maintains | |
| 2021-02-08 | Deutsche Bank | Hold | Maintains | |
| 2021-02-08 | Raymond James | Strong Buy | Maintains | |
| 2021-02-08 | Morgan Stanley | Overweight | Maintains | |
| 2021-02-08 | SVB Leerink | Outperform | Maintains | |
| 2021-02-05 | Needham | Strong Buy | Maintains | |
| 2021-01-27 | JMP Securities | Market Outperform | Maintains | |
| 2021-01-25 | BTIG | Buy | Maintains | |
| 2021-01-04 | Evercore ISI Group | In-Line | Outperform | Upgrade |
| 2020-12-15 | Morgan Stanley | Overweight | Maintains | |
| 2020-12-14 | SVB Leerink | Outperform | Maintains | |
| 2020-11-09 | Credit Suisse | Underperform | Maintains | |
| 2020-11-09 | SVB Leerink | Outperform | Maintains | |
| 2020-10-20 | Northland Capital Markets | Market Perform | Initiate | |
| 2020-10-12 | Raymond James | Strong Buy | Maintains | |
| 2020-10-05 | SVB Leerink | Outperform | Maintains | |
| 2020-09-11 | Wolfe Research | Outperform | Initiate | |
| 2020-08-05 | Morgan Stanley | Overweight | Maintains | |
| 2020-08-05 | Needham | Strong Buy | Maintains | |
| 2020-08-05 | SVB Leerink | Outperform | Maintains | |
| 2020-08-05 | Raymond James | Strong Buy | Maintains | |
| 2020-07-15 | SVB Leerink | Outperform | Maintains | |
| 2020-05-18 | JMP Securities | Market Outperform | Maintains | |
| 2020-05-12 | Stifel | Buy | Maintains | |
| 2020-05-12 | Citigroup | Buy | Maintains | |
| 2020-05-12 | Canaccord Genuity | Buy | Maintains | |
| 2020-05-12 | UBS | Buy | Maintains | |
| 2020-05-12 | Oppenheimer | Outperform | Maintains | |
| 2020-05-12 | Wells Fargo | Overweight | Maintains | |
| 2020-05-12 | Deutsche Bank | Hold | Maintains | |
| 2020-05-12 | SunTrust Robinson Humphrey | Buy | Maintains | |
| 2020-05-12 | SVB Leerink | Outperform | Maintains | |
| 2020-05-12 | Raymond James | Strong Buy | Maintains | |
| 2020-05-11 | Needham | Strong Buy | Maintains | |
| 2020-04-28 | Guggenheim | Buy | Neutral | Downgrade |
| 2020-04-13 | Raymond James | Strong Buy | Maintains | |
| 2020-04-09 | Evercore ISI Group | Outperform | In-Line | Downgrade |
| 2020-04-07 | BTIG | Buy | Maintains | |
| 2020-04-07 | SunTrust Robinson Humphrey | Buy | Maintains | |
| 2020-04-07 | SVB Leerink | Outperform | Maintains | |
| 2020-04-07 | Needham | Strong Buy | Maintains | |
| 2020-03-27 | Citigroup | Buy | Maintains | |
| 2020-03-27 | Morgan Stanley | Overweight | Maintains | |
| 2020-03-24 | Stifel | Buy | Maintains | |
| 2020-03-06 | Credit Suisse | Underperform | Maintains | |
| 2020-03-05 | Citigroup | Buy | Initiate | |
| 2020-02-13 | Goldman Sachs | Buy | Initiate | |
| 2020-02-05 | Deutsche Bank | Hold | Maintains | |
| 2020-02-05 | Baird | Outperform | Maintains | |
| 2020-02-05 | Credit Suisse | Underperform | Maintains | |
| 2020-02-05 | Morgan Stanley | Overweight | Maintains | |
| 2020-02-05 | Raymond James | Strong Buy | Maintains | |
| 2020-02-04 | Needham | Strong Buy | Reiterate | |
| 2020-01-10 | Wells Fargo | Overweight | Maintains | |
| 2020-01-08 | SunTrust Robinson Humphrey | Buy | Initiate | |
| 2020-01-07 | Piper Sandler | Neutral | Overweight | Upgrade |
| 2019-12-19 | Needham | Strong Buy | Maintains | |
| 2019-12-17 | Morgan Stanley | Overweight | Maintains | |
| 2019-12-04 | Raymond James | Outperform | Strong Buy | Upgrade |
| 2019-11-06 | Raymond James | Outperform | Maintains | |
| 2019-11-06 | UBS | Buy | Maintains | |
| 2019-11-06 | RBC Capital | Outperform | Maintains | |
| 2019-10-07 | BTIG | Neutral | Buy | Upgrade |
| 2019-09-18 | Canaccord Genuity | Hold | Buy | Upgrade |
| 2019-09-09 | Wells Fargo | Outperform | Maintains | |
| 2019-08-12 | Argus | Hold | Buy | Upgrade |
| 2019-08-02 | Citi | Buy | Maintains | |
| 2019-07-30 | Barclays | Underweight | Equal-Weight | Upgrade |
| 2019-07-29 | Wells Fargo | Outperform | Maintains | |
| 2019-07-29 | Raymond James | Outperform | Maintains | |
| 2019-07-29 | Baird | Neutral | Outperform | Upgrade |
| 2019-07-29 | Morgan Stanley | Overweight | Maintains | |
| 2019-06-11 | Bernstein | Underperform | Market Perform | Upgrade |
| 2019-04-24 | Needham | Buy | Strong Buy | Upgrade |
| 2019-04-15 | Barclays | Underweight | Underweight | Maintains |
| 2019-04-08 | Evercore ISI Group | In-Line | Outperform | Upgrade |
| 2019-03-04 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2019-01-03 | Deutsche Bank | Hold | Initiate | |
| 2019-01-02 | Citigroup | Neutral | Buy | Upgrade |
| 2019-01-02 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-12-19 | JP Morgan | Overweight | Neutral | Downgrade |
| 2018-12-18 | Credit Suisse | Underperform | Initiate | |
| 2018-11-28 | UBS | Buy | Initiate | |
| 2018-10-29 | Jefferies | Buy | Buy | Maintains |
| 2018-10-29 | Barclays | Underweight | Underweight | Maintains |
| 2018-10-29 | Citigroup | Neutral | Neutral | Maintains |
| 2018-10-16 | Barclays | Underweight | Initiate | |
| 2018-10-11 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-08-16 | BTIG Research | Neutral | Initiate | |
| 2018-08-13 | Needham | Strong Buy | Buy | Downgrade |
| 2018-07-31 | Citigroup | Neutral | Neutral | Maintains |
| 2018-07-30 | Baird | Neutral | Neutral | Maintains |
| 2018-07-30 | Cantor Fitzgerald | Overweight | Overweight | Maintains |
| 2018-07-30 | Canaccord Genuity | Hold | Hold | Maintains |
| 2018-07-30 | Raymond James | Outperform | Outperform | Maintains |
| 2018-07-30 | JMP Securities | Market Outperform | Market Outperform | Maintains |
| 2018-06-27 | Bernstein | Underperform | Initiate | |
| 2018-06-22 | Argus | Buy | Hold | Downgrade |
| 2018-04-27 | JMP Securities | Market Outperform | Market Outperform | Maintains |
| 2018-04-27 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-04-03 | Evercore ISI Group | In-Line | Initiate | |
| 2018-03-23 | Baird | Outperform | Neutral | Downgrade |
| 2018-03-15 | Raymond James | Outperform | Initiate | |
| 2018-02-28 | Citigroup | Neutral | Neutral | Maintains |
| 2018-02-27 | Citigroup | Neutral | Neutral | Maintains |
| 2018-02-26 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-01-31 | Stifel Nicolaus | Hold | Buy | Upgrade |
| 2018-01-31 | Leerink Swann | Outperform | Outperform | Maintains |
| 2017-12-20 | Goldman Sachs | Sell | Neutral | Upgrade |
| 2017-11-14 | Deutsche Bank | Hold | Buy | Upgrade |
| 2017-11-09 | Edward Jones | Hold | Buy | Upgrade |
| 2017-11-02 | Morgan Stanley | Overweight | Maintains | |
| 2017-11-02 | PiperJaffray | Overweight | Neutral | Downgrade |
| 2017-11-02 | BMO Capital | Outperform | Maintains | |
| 2017-08-24 | Gabelli & Co. | Buy | Initiate | |
| 2017-07-28 | BMO Capital | Outperform | Maintains | |
| 2017-07-28 | Canaccord Genuity | Buy | Hold | Downgrade |
| 2017-07-28 | Leerink Swann | Outperform | Maintains | |
| 2017-07-17 | Morgan Stanley | Overweight | Maintains | |
| 2017-07-12 | Guggenheim | Neutral | Buy | Upgrade |
| 2017-06-30 | Cantor Fitzgerald | Neutral | Initiate | |
| 2017-05-16 | Goldman Sachs | Sell | Initiate | |
| 2017-04-28 | Wells Fargo | Outperform | Market Perform | Downgrade |
| 2016-12-15 | UBS | Neutral | Sell | Downgrade |
| 2016-11-08 | Northcoast Research | Buy | Neutral | Downgrade |
| 2016-11-01 | Needham | Buy | Strong Buy | Upgrade |
| 2016-08-23 | Barclays | Overweight | Maintains | |
| 2016-08-11 | SunTrust Robinson Humphrey | Buy | Initiate | |
| 2016-08-02 | UBS | Neutral | Maintains | |
| 2016-07-29 | JP Morgan | Overweight | Maintains | |
| 2016-07-29 | Jefferies | Buy | Maintains | |
| 2016-07-29 | Barclays | Overweight | Maintains | |
| 2016-07-29 | JMP Securities | Market Outperform | Maintains | |
| 2016-07-29 | Citigroup | Sell | Maintains | |
| 2016-06-09 | Guggenheim | Neutral | Initiate | |
| 2016-05-02 | Leerink Swann | Outperform | Maintains | |
| 2016-03-17 | Nomura | Buy | Initiate | |
| 2016-03-04 | Argus | Buy | Hold | Downgrade |
| 2016-01-29 | Credit Suisse | Outperform | Maintains | |
| 2016-01-27 | JMP Securities | Market Outperform | Maintains | |
| 2016-01-07 | Northland Securities | Outperform | Market Perform | Downgrade |
| 2015-11-12 | Citigroup | Sell | Initiate | |
| 2015-11-04 | Sterne Agee CRT | Buy | Initiate | |
| 2015-07-08 | Goldman Sachs | Neutral | Initiate | |
| 2025-08-08 | Raymond James | Outperform | Outperform | Maintains |
| 2025-08-08 | UBS | Sell | Sell | Maintains |
| 2025-08-08 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-05-12 | Canaccord Genuity | Hold | Hold | Maintains |
| 2025-05-06 | JP Morgan | Overweight | Overweight | Maintains |
| 2025-05-06 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2025-05-06 | Baird | Outperform | Outperform | Maintains |
| 2025-05-07 | JMP Securities | Market Outperform | Market Outperform | Maintains |
